Advanced Biomed Inc. 8-K

What Happened

• Advanced Biomed Inc. (ADVB) filed a Form 8-K on March 30, 2026 reporting that on March 25, 2026 Steven I‑Fang Cheng resigned as a director and as Chief Technology Officer, effective that same date. The company said the resignation was not due to any disagreement with the company’s operations, policies, or practices.
• On March 25, 2026 the Board, upon the Nominating Committee’s recommendation, appointed Mingze Yin — the company’s Chief Financial Officer — to the Board of Directors, effective March 25, 2026.

Key Details

• Resignation effective date: March 25, 2026 (Steven I‑Fang Cheng: director and CTO).
• New director appointment effective date: March 25, 2026 (Mingze Yin, CFO).
• Filing: Form 8-K (Item 5.02) filed March 30, 2026.
• Disclosure: Company states no family relationships, no special arrangements for Mr. Yin, and no transactions requiring Item 404(a) disclosure.

Why It Matters

• Board and management change: The CTO departure reduces technical leadership at the executive level, while the CFO’s appointment adds financial leadership to the board, which may affect governance and oversight dynamics.
• Continuity and disclosure: The company reported the resignation was not due to any disagreement and provided routine disclosures about the new director’s independence from special arrangements or reportable transactions — useful facts for investors tracking governance and leadership stability.